Stephen Power
University of Western Ontario
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen Power.
The Journal of Steroid Biochemistry and Molecular Biology | 1992
Carolyn L. Smith; Stephen Power; Geoffrey L. Hammond
A steroid binding capacity assay and a radioimmunoassay were both used to measure corticosteroid binding globulin (CBG) in serum samples from 22 patients with sepsis. An approximately 50% discordancy between the two values in one patient suggested the presence of a CBG variant with reduced affinity for cortisol, and this was confirmed by Scatchard analysis. We therefore used the polymerase chain reaction to amplify exons that encode for human CBG from the genomic DNA of this patient. This revealed two mutations within the coding sequences: one of which results in a Leu----His substitution at residue 93 and another which encodes a Ser----Ala substitution at residue 224 of the human CBG polypeptide. To assess the impact of each substitution on the steroid binding affinity of CBG, each mutation was introduced separately into a normal human CBG cDNA, and the normal and mutated cDNAs were expressed in Chinese hamster ovary cells. Scatchard analysis of the CBG produced in culture indicated that the His93 mutation (Kd = 2.24 +/- 1.75 nM) reduced the cortisol binding affinity of CBG (mean +/- SD) significantly (P less than 0.024) when compared to normal CBG (Kd = 0.64 +/- 0.31 nM), while the Ala224 mutation (Kd = 0.63 +/- 0.33 nM) did not influence cortisol binding affinity. We therefore conclude that residue 93 may play an important role in determining the structure of the CBG steroid binding site.
Scientific Reports | 2015
Carlee R. White; Michelle M. Denomme; Francis R. Tekpetey; Valter Feyles; Stephen Power; Mellissa R.W. Mann
Assisted reproductive technologies (ARTs) represent the best chance for infertile couples to conceive, although increased risks for morbidities exist, including imprinting disorders. This increased risk could arise from ARTs disrupting genomic imprints during gametogenesis or preimplantation. The few studies examining ART effects on genomic imprinting primarily assessed poor quality human embryos. Here, we examined day 3 and blastocyst stage, good to high quality, donated human embryos for imprinted SNRPN, KCNQ1OT1 and H19 methylation. Seventy-six percent day 3 embryos and 50% blastocysts exhibited perturbed imprinted methylation, demonstrating that extended culture did not pose greater risk for imprinting errors than short culture. Comparison of embryos with normal and abnormal methylation didn’t reveal any confounding factors. Notably, two embryos from male factor infertility patients using donor sperm harboured aberrant methylation, suggesting errors in these embryos cannot be explained by infertility alone. Overall, these results indicate that ART human preimplantation embryos possess a high frequency of imprinted methylation errors.
Steroids | 1993
Hugo Van Baelen; Stephen Power; Geoffrey L. Hammond
Genomic DNA was isolated from two related individuals who are homozygous for transcortin Leuven, a corticosteroid-binding globulin variant with decreased cortisol-binding affinity. This material was amplified using intron-specific oligonucleotide primers in a polymerase chain reaction to obtain the four exons that encode transcortin. Sequence analysis of these exons showed several mutations within the coding sequence of both individuals, but only one of these will result in an amino acid substitution. This mutation is located within exon 2 and alters the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes.
Human Fertility | 2016
George Puthenpurayil Jacob; A. Oraif; Stephen Power
Abstract This commentary reviews some of the major papers that have been published on the effect of ovarian reserve after surgical interventions. At the end, the authors outline a summary on the effect of these interventions, in terms of future fertility and menopause.
Journal SOGC | 1999
Melanie Chanda; Stephen Power
Abstract Retained fetal parts following a midtrimester termination of pregnancy are an unusual cause of secondary infertility. The resultant endometrial ossification may prevent subsequent pregnancy by a mechanism similar to that of an intra-uterine contraceptive device. Other symptoms which have been described include menstrual disturbances and persistent vaginal discharge. Investigation of women with a suggestive history should include ultrasound of the endometrial cavity. The diagnosis is frequently missed by hysterosalpingography. Hysteroscopy is valuable for making the definitive diagnosis and for therapy. Removal of the osseous tissue has been associated with a resumption of fertility. An illustrative case and review of the literature are presented.
Molecular Endocrinology | 1997
Marja Jänne; Harminder K. Deol; Stephen Power; Siu-Pok Yee; Geoffrey L. Hammond
Fertility and Sterility | 2007
Christopher Newton; Joanna McBride; Valter Feyles; Francis R. Tekpetey; Stephen Power
The Journal of Clinical Endocrinology and Metabolism | 1992
Stephen Power; W. P. Bocchinfuso; M. Pallesen; S. Warmels-Rodenhiser; H. Van Baelen; Geoffrey L. Hammond
Fertility and Sterility | 2007
Fawaz Edris; Cecelia M. Kerner; Valter Feyles; Andrew Leung; Stephen Power
Endocrinology | 1982
Stephen Power; John E. Patrick; George D. Carson; John R. G. Challis